$PETS
PETMED EXPRESS INC

2021 Q1 Form 10-Q Financial Statement

#000143774921001245 Filed on January 26, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4 2019 Q4
Revenue $71.68M $65.90M $59.92M
YoY Change -3.51% 9.98% -0.25%
Cost Of Revenue $51.16M $46.27M $42.22M
YoY Change -2.74% 9.6% 3.76%
Gross Profit $20.52M $19.62M $17.70M
YoY Change -5.37% 10.88% -8.69%
Gross Profit Margin 28.63% 29.78% 29.54%
Selling, General & Admin $11.50M $9.710M $9.200M
YoY Change -8.87% 5.54% -2.23%
% of Gross Profit 56.04% 49.48% 51.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $640.0K $622.0K $562.0K
YoY Change 14.29% 10.68% 1.08%
% of Gross Profit 3.12% 3.17% 3.18%
Operating Expenses $12.13M $10.33M $9.765M
YoY Change -7.9% 5.79% -2.04%
Operating Profit $8.387M $9.293M $7.932M
YoY Change -1.48% 17.16% -15.73%
Interest Expense $90.00K $70.00K $420.0K
YoY Change -70.0% -83.33% -17.65%
% of Operating Profit 1.07% 0.75% 5.3%
Other Income/Expense, Net $380.0K $418.0K $722.0K
YoY Change 22.58% -42.11% -5.37%
Pretax Income $8.850M $9.711M $8.654M
YoY Change -2.96% 12.21% -14.96%
Income Tax $2.040M $2.100M $1.800M
% Of Pretax Income 23.05% 21.62% 20.8%
Net Earnings $6.812M $7.611M $6.840M
YoY Change -2.73% 11.27% -12.16%
Net Earnings / Revenue 9.5% 11.55% 11.42%
Basic Earnings Per Share $0.38 $0.34
Diluted Earnings Per Share $0.34 $0.38 $0.34
COMMON SHARES
Basic Shares Outstanding 20.27M 20.09M 19.98M
Diluted Shares Outstanding 20.10M 19.99M

Balance Sheet

Concept 2021 Q1 2020 Q4 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $118.7M $106.5M $92.40M
YoY Change 14.35% 15.26% -0.86%
Cash & Equivalents $118.7M $106.5M $92.37M
Short-Term Investments
Other Short-Term Assets $5.500M $4.500M $4.200M
YoY Change 57.14% 7.14% 223.08%
Inventory $34.40M $28.20M $24.20M
Prepaid Expenses
Receivables $2.587M $1.831M $2.052M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $161.2M $141.0M $122.8M
YoY Change 24.93% 14.86% -4.44%
LONG-TERM ASSETS
Property, Plant & Equipment $25.45M $25.50M $25.92M
YoY Change 0.02% -1.6% -6.04%
Goodwill
YoY Change
Intangibles $860.0K $860.0K $860.0K
YoY Change 0.0% 0.0% 0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $26.31M $26.36M $26.78M
YoY Change 0.02% -1.55% -5.86%
TOTAL ASSETS
Total Short-Term Assets $161.2M $141.0M $122.8M
Total Long-Term Assets $26.31M $26.36M $26.78M
Total Assets $187.5M $167.4M $149.5M
YoY Change 20.71% 11.92% -4.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $39.55M $21.87M $16.64M
YoY Change 101.18% 31.46% -17.99%
Accrued Expenses $5.400M $4.400M $3.200M
YoY Change 28.57% 37.5% 14.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $44.94M $26.92M $20.73M
YoY Change 84.59% 29.9% -10.09%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $44.94M $26.92M $20.73M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $46.22M $28.24M $21.83M
YoY Change 82.58% 29.36% -9.25%
SHAREHOLDERS EQUITY
Retained Earnings $134.1M $133.0M $124.6M
YoY Change 6.31% 6.73% 2.88%
Common Stock $20.00K $20.00K $20.00K
YoY Change 0.0% 0.0% -4.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $141.3M $139.1M $127.7M
YoY Change
Total Liabilities & Shareholders Equity $187.5M $167.4M $149.5M
YoY Change 20.71% 11.92% -4.7%

Cashflow Statement

Concept 2021 Q1 2020 Q4 2019 Q4
OPERATING ACTIVITIES
Net Income $6.812M $7.611M $6.840M
YoY Change -2.73% 11.27% -12.16%
Depreciation, Depletion And Amortization $640.0K $622.0K $562.0K
YoY Change 14.29% 10.68% 1.08%
Cash From Operating Activities $18.45M $6.440M $4.290M
YoY Change 6.89% 50.12% -63.11%
INVESTING ACTIVITIES
Capital Expenditures -$580.0K -$660.0K -$1.410M
YoY Change 20.83% -53.19% 2250.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$580.0K -$660.0K -$1.410M
YoY Change 20.83% -53.19% 2250.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.650M -5.630M -5.400M
YoY Change 4.82% 4.26% -2.35%
NET CHANGE
Cash From Operating Activities 18.45M 6.440M 4.290M
Cash From Investing Activities -580.0K -660.0K -1.410M
Cash From Financing Activities -5.650M -5.630M -5.400M
Net Change In Cash 12.22M 150.0K -2.520M
YoY Change 7.29% -105.95% -141.72%
FREE CASH FLOW
Cash From Operating Activities $18.45M $6.440M $4.290M
Capital Expenditures -$580.0K -$660.0K -$1.410M
Free Cash Flow $19.03M $7.100M $5.700M
YoY Change 7.27% 24.56% -51.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2020Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20271000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20271000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20166000
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20166000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
130326
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
72120
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106501000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103762000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1831000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3843000 USD
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20271122
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
28000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
59000 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3000
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3000
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
28165000 USD
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
17884000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4512000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3529000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
141009000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
129018000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25502000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25445000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000 USD
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
26362000 USD
CY2020Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
26305000 USD
CY2020Q4 us-gaap Assets
Assets
167371000 USD
CY2020Q1 us-gaap Assets
Assets
155323000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
21869000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
19658000 USD
CY2020Q4 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
4429000 USD
CY2020Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
4214000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
623000 USD
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
471000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26921000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
24343000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1323000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
970000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
28244000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
25313000 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
9000 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
9000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
20000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
20000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6098000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3804000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
133000000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
126177000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
139127000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
130010000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
167371000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
155323000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
65896000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
59915000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
237536000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
209839000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46273000 USD
CY2019Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
42218000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
168110000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
150279000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
19623000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
17697000 USD
us-gaap Gross Profit
GrossProfit
69426000 USD
us-gaap Gross Profit
GrossProfit
59560000 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6487000 USD
CY2019Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6040000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21050000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18851000 USD
CY2020Q4 us-gaap Advertising Expense
AdvertisingExpense
3221000 USD
CY2019Q4 us-gaap Advertising Expense
AdvertisingExpense
3163000 USD
us-gaap Advertising Expense
AdvertisingExpense
17385000 USD
us-gaap Advertising Expense
AdvertisingExpense
16543000 USD
CY2020Q4 us-gaap Depreciation
Depreciation
622000 USD
CY2019Q4 us-gaap Depreciation
Depreciation
562000 USD
us-gaap Depreciation
Depreciation
1791000 USD
us-gaap Depreciation
Depreciation
1702000 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
10330000 USD
CY2019Q4 us-gaap Operating Expenses
OperatingExpenses
9765000 USD
us-gaap Operating Expenses
OperatingExpenses
40226000 USD
us-gaap Operating Expenses
OperatingExpenses
37096000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
9293000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
7932000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
29200000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
22464000 USD
CY2020Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
73000 USD
CY2019Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
421000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
229000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1447000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
345000 USD
CY2019Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
301000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
938000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
862000 USD
CY2020Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
418000 USD
CY2019Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
722000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1167000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2309000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9711000 USD
CY2019Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8654000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
30367000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24773000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2100000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1814000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6576000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5925000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
7611000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
6840000 USD
us-gaap Net Income Loss
NetIncomeLoss
23791000 USD
us-gaap Net Income Loss
NetIncomeLoss
18848000 USD
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.94
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20094000
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19984000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20047000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20060000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20104000
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19994000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20100000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20071000
CY2020Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.28
CY2019Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.27
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.84
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.81
us-gaap Net Income Loss
NetIncomeLoss
23791000 USD
us-gaap Net Income Loss
NetIncomeLoss
18848000 USD
us-gaap Depreciation
Depreciation
1791000 USD
us-gaap Depreciation
Depreciation
1702000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2294000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2081000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
353000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-12000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
84000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
102000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1928000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-388000 USD
us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
10281000 USD
us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
2795000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-0 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-582000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
983000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1424000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2211000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
360000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
286000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
851000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
152000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
895000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21626000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21578000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1848000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1827000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1848000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1827000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11496000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
17039000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
16410000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17039000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27906000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2739000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8155000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
103762000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
100529000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
106501000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
92374000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
6356000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
4460000 USD
pets Transfer Of Property And Equipment To Current Assets
TransferOfPropertyAndEquipmentToCurrentAssets
0 USD
pets Transfer Of Property And Equipment To Current Assets
TransferOfPropertyAndEquipmentToCurrentAssets
1344000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
174000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
196000 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Use of Estimates</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;">The preparation of Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:0pt;margin-right:36pt;margin-top:0pt;text-align:justify;"> </p>
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
65896000 USD
CY2020Q4 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2019Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
59915000 USD
CY2019Q4 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2020Q4 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
5981000 USD
CY2020Q4 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.100 pure
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
65896000 USD
CY2020Q4 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2019Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
59915000 USD
CY2019Q4 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2020Q4 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
5981000 USD
CY2020Q4 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.100 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
237536000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
209839000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
27697000 USD
pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.132 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
237536000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
209839000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
27697000 USD
pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.132 pure
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
7611000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
6840000 USD
us-gaap Net Income Loss
NetIncomeLoss
23791000 USD
us-gaap Net Income Loss
NetIncomeLoss
18848000 USD
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20094000
CY2019Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19984000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20047000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20060000
CY2020Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2019Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
43000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1000
CY2020Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2019Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20104000
CY2019Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19994000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20100000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20071000
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.94
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
130326
CY2019Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
72120
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106500000 USD
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
613000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
11500000 USD
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2020Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
28700000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2100000 USD
CY2019Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1800000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6600000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5900000 USD
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.216 pure
CY2019Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.217 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.239 pure
CY2020 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
194000 USD
CY2019 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
93000 USD
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
285000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
106000 USD
CY2019Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
322000 USD

Files In Submission

Name View Source Status
0001437749-21-001245-index-headers.html Edgar Link pending
0001437749-21-001245-index.html Edgar Link pending
0001437749-21-001245.txt Edgar Link pending
0001437749-21-001245-xbrl.zip Edgar Link pending
ex_221931.htm Edgar Link pending
ex_221932.htm Edgar Link pending
ex_221933.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pets-20201231.xsd Edgar Link pending
pets-20201231_cal.xml Edgar Link unprocessable
pets-20201231_def.xml Edgar Link unprocessable
pets-20201231_lab.xml Edgar Link unprocessable
pets-20201231_pre.xml Edgar Link unprocessable
pets20201231_10q.htm Edgar Link pending
pets20201231_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending